Safety and Pharmacokinetics of ODM-208 in Patients With Metastatic Castration-resistant Prostate Cancer
Status:
Recruiting
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this first-in-man study is to evaluate safety and tolerability of ODM-208 in
patients with metastatic castration-resistant prostate cancer.